<DOC>
	<DOCNO>NCT01228994</DOCNO>
	<brief_summary>The primary hypothesis study , nicotine-dependent tobacco smoker , baclofen superior placebo smoke abstinence measure . The secondary hypothesis subject assign baclofen group exhibit high rate medication compliance ( i.e . take medication direct trial period ) placebo group . The tertiary hypothesis baclofen lead significant reduction tobacco withdrawal crave rating compare placebo .</brief_summary>
	<brief_title>Baclofen Smoking Cessation Non-Psychiatric Population</brief_title>
	<detailed_description>This study test new medication strategy design help smoker quit . It evaluate Baclofen , drug currently approve available Canada myorelaxant . Forty five nicotine-dependent smoker enroll study . Fifteen receive placebo ( inactive pill ) , fifteen receive baclofen 30 mg/day , fifteen receive baclofen 60 mg/day . Once enrol , subject visit CAMH weekly basis assessment smoke behaviour , brief health check ( vitals , BP AE screen ) , delivery brief individual smoking cessation counselling , collection breath , blood urine sample ( schedule ) ) measure level nicotine metabolite , b ) conduct pregnancy tox test . The medication phase study last 12 week . Two follow-up visit schedule week 13 six month trial completion .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Baclofen</mesh_term>
	<criteria>Male female adult ( 18 year old ) . Meet DSMIV criterion nicotine dependence , Smoke ≥10 cigarettes/day , Baseline FTND score ≥4 , CO level ≥10 , least one fail quit attempt past motivated quit within 30 day initial intake . No previous use medication smoke cessation 1 month prior randomization . BMI 15 40 inclusive . Meet DSMIV criterion current diagnosis major depressive disorder , panic disorder posttraumatic stress disorder , current past history bipolar disorder schizophrenia Have past history major depression , historical evidence suicidal homicidal behaviour , psychotic symptom , Have abuse alcohol drug abuse ( cocaine , opiates , benzodiazepine , etc ) 3 month prior randomization Demonstrate serious medical condition , unstable cardiovascular disease , significant blood abnormality ) Are pregnant , try become pregnant currently breastfeed Baclofen hypersensitivity .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>smoke cessation treatment</keyword>
	<keyword>baclofen</keyword>
	<keyword>Smoking cessation counselling</keyword>
</DOC>